Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Healthcare Copper
Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Medivolve Inc > QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(7)
•••
Comment by TotalCorruptionon Jan 04, 2021 10:02pm
122 Views
Post# 32221393

RE:QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....

RE:QSC $ 5 million PP INCREASES PROFIT MARGINS to 65%.....I agree QSC never needed pumping! I agree it needed financing. Cannacord will mess this up I believe in a nasty way. I totally believe in this biz & just have seen Cannacord at work for 35 years. Ugh. This been played with and I now feel I understand why. They are why. CEO should have chiselled out a way better deal. I'm obviously not happy lol. Biz is good enough to maybe foil their scumbag tactics but up to now hasn't done that. Should be easy at .60-.80. But instead was pushed back to .16 and then today .35 from .50 which was downright silly. I'd like real trading & much less manipulation but I don't see that coming with Cannacord involved. 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities